Hepatobiliary Surgery Practice Questions

Q: All of the following may lead to gall bladder carcinoma except which of the following?

Echinococcus Granulosus Infection. ***Echinococcus Granulosus Infection*** - Echinococcus granulosus is primarily associated with **hydatid cyst formation**, not directly linked to gallbladder carcinoma. - This infection typically affects the **liver** rather than inducing malignant transformation in the gallbladder. *Typhoid carriers* - Chronic infection with **Salmonella typhi** in carriers can cause **gallbladder inflammation** and is a risk factor for gallbladder cancer. - Typhoid carriers retain the bacteria in the gallbladder, leading to chronic irritation and potentially malignant changes. *Gall Bladder Polyps* - Certain types of gallbladder polyps, especially those larger than **1 cm**, have a significant risk of undergoing malignant transformation. - They are associated with **chronic inflammation** and may progress to cancer if not monitored. *Exposure to carcinogens like nitrosamine* - Nitrosamines are known **carcinogens** that can induce protein modifications leading to DNA damage, contributing to gallbladder cancer. - Long-term exposure to such chemicals can result in **cellular mutations** in the gallbladder epithelial lining.

Q: A 60-year-old male presented with jaundice, pale stools, dark urine, and a mass in the epigastric region. Which of the following diagnoses is least likely to be the cause of these symptoms?

Chronic Cholecystitis. ***Chronic Cholecystitis*** - While chronic cholecystitis can cause epigastric pain, it rarely presents with **jaundice**, **pale stools**, and **dark urine** because it typically does not obstruct the common bile duct. - The presence of a palpable **epigastric mass** is also not a common feature of chronic cholecystitis. *Biliary Cancer* - **Biliary cancer**, particularly choledochal cancer, can cause **obstructive jaundice**, leading to **pale stools** (lack of bilirubin) and **dark urine** (conjugated bilirubin in urine). - A mass in the **epigastric region** could represent an enlarged gallbladder due to distal obstruction (Courvoisier's sign) or the tumor itself. *Periampullary Cancer* - **Periampullary cancers**, which arise near the ampulla of Vater, characteristically cause **obstructive jaundice**, presenting with **pale stools** and **dark urine**. - A mass in the **epigastric region** might be the tumor or a dilated gallbladder due to bile duct obstruction. *Pancreatic cancer* - **Pancreatic head cancer** frequently obstructs the common bile duct, resulting in **jaundice**, **pale stools**, and **dark urine**. - An **epigastric mass** can be the palpable tumor itself or an enlarged, distended gallbladder.

Q: Which of the following statements about Gallbladder carcinoma is true?

Gallstones may be a predisposing factor. ***Gallstones may be a predisposing factor*** - The chronic inflammation and irritation caused by **gallstones (cholelithiasis)** are considered major risk factors for the development of gallbladder carcinoma. - Approximately 70-90% of patients with gallbladder carcinoma also have **cholelithiasis**, suggesting a strong association. *Carries a good prognosis* - Gallbladder carcinoma generally has a **poor prognosis** due to its asymptomatic nature in early stages and aggressive local invasion. - Most cases are diagnosed at an advanced stage, leading to a **low 5-year survival rate**. *Commonly squamous cell carcinoma* - The vast majority of gallbladder carcinomas are **adenocarcinomas** (around 90%), arising from the glandular epithelium. - **Squamous cell carcinoma** is rare, accounting for only a small percentage of cases. *Jaundice is rare* - **Jaundice** is a common symptom in advanced gallbladder carcinoma, often indicating obstruction of the biliary ducts. - It arises when the tumor invades or compresses the **common bile duct**, leading to bilirubin backup.

Q: In which of the following conditions is ERCP not indicated?

Proximal cholangiocarcinoma. ***Proximal cholangiocarcinoma*** - For **proximal/hilar cholangiocarcinoma** (Klatskin tumors at the **hepatic hilum**), **PTBD (Percutaneous Transhepatic Biliary Drainage)** is generally preferred over ERCP for biliary drainage. - The **high location** of these tumors makes endoscopic access difficult, with lower success rates and higher risk of complications like **cholangitis** and incomplete drainage. - **ERCP may fail** to adequately drain both hepatic ducts in bifurcation tumors, making PTBD the more reliable first-line approach. *Hepatic porta tumor* - **Hepatic porta tumors** involving the bile ducts are anatomically similar to **proximal cholangiocarcinoma**. - While ERCP can occasionally be attempted for porta hepatis lesions, **PTBD is often preferred** for high biliary obstructions due to better access to intrahepatic ducts. - The distinction is subtle, but **proximal cholangiocarcinoma** specifically refers to Klatskin tumors where ERCP has the **highest failure rate** and PTBD is most strongly preferred. *Distal CBD tumor* - **ERCP is the preferred modality** for **distal CBD tumors** to provide **biliary drainage**, tissue sampling (biopsy), and stent placement to relieve obstruction. - Direct endoscopic access to the distal common bile duct makes ERCP highly effective for diagnosis and palliation in this region. *Gallstone pancreatitis* - **ERCP is indicated** in **gallstone pancreatitis** when there is evidence of **cholangitis** or persistent **biliary obstruction** (e.g., rising liver enzymes, imaging showing retained stone in the CBD). - It allows for **therapeutic removal of impacted stones** from the common bile duct, preventing further pancreatic inflammation and complications.

Q: All of the following are causes of hemobilia, EXCEPT:

Hepatitis. ***Hepatitis*** - **Hepatitis** is an inflammation of the liver, typically caused by viral infections, alcohol, or autoimmune processes. While it can lead to liver damage and dysfunction, it does not typically cause **hemobilia**. - **Hemobilia** involves bleeding into the biliary tree, which is usually a result of vascular-biliary fistula formation; hepatitis primarily affects liver parenchymal cells and does not directly result in this type of bleeding. *Trauma to Abdomen* - **Abdominal trauma**, especially liver injuries, can lead to **vascular-biliary fistulae** or direct bleeding into the bile ducts, causing **hemobilia**. - Blunt or penetrating trauma can damage the liver parenchyma and blood vessels, allowing blood to enter the biliary system. *Malignancy* - **Malignant tumors** of the liver or biliary tract (e.g., **cholangiocarcinoma**, **hepatocellular carcinoma**) can erode into blood vessels and bile ducts, leading to **hemobilia**. - The growth of these tumors can rupture fragile vessels within the tumor or adjacent to it, causing blood to leak into the biliary tree. *Rupture of hepatic artery aneurysm* - A ruptured **hepatic artery aneurysm** is a significant and direct cause of **hemobilia**. - The forceful bleeding from the artery can breach the wall of an adjacent bile duct, creating a **fistula** and allowing arterial blood to enter the biliary system.

Q: In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?

Type II. ***Type II*** - This classification specifically describes **cholangiocarcinomas** located at the **hepatic duct confluence** without extension into secondary intrahepatic ducts. - **Type II tumors** involve the hepatic duct confluence but **do not extend** into the right or left secondary intrahepatic ducts. - This is the defining feature that distinguishes Type II from Type III variants. *Type I* - **Type I tumors** are located at least **2 cm distal to the hepatic duct bifurcation**. - This type involves the **common hepatic duct** and **spares the confluence** completely. - Does not meet the criteria of involving the confluence. *Type IIIa* - **Type IIIa tumors** involve the **hepatic duct confluence** with extension into the **right secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension into secondary ducts is the key differentiating feature. *Type IIIb* - **Type IIIb tumors** involve the **hepatic duct confluence** with extension into the **left secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension pattern differs from Type IIIa by involving the left rather than right system.

Q: In a patient with acute cholecystitis, referred pain to the shoulder is known as

Boas' sign. ***Boas' sign*** - **Boas' sign** refers to the presence of hyperesthesia below the right scapula, which can also manifest as referred pain to the **right shoulder** or back [1]. - This symptom in acute cholecystitis is due to the **irritation** of the **phrenic nerve**, which shares sensory pathways with the shoulder region. *Murphy's sign* - **Murphy's sign** is elicited by asking the patient to exhale, then placing the examiner's hand below the costal margin on the right mid-clavicular line, and then asking the patient to inhale deeply [1]. - A positive sign is indicated by a sudden cessation of inspiration due to pain, which is specific for **acute cholecystitis** and not referred shoulder pain [1]. *Gray Turner sign* - The **Gray Turner sign** involves ecchymosis or discoloration of the flanks. - It is a severe indicator of **retroperitoneal hemorrhage**, often associated with acute pancreatitis, not cholecystitis [2]. *Cullen's sign* - **Cullen's sign** presents as periumbilical ecchymosis or discoloration around the navel. - This sign is also indicative of **retroperitoneal hemorrhage**, typically seen in serious conditions like ruptured ectopic pregnancy or acute pancreatitis.

Q: What is the standard intercostal space used for hepatic biopsy?

9th. ***Correct Option: 9th*** - The **9th intercostal space** in the mid-axillary line is the standard and most commonly used entry point for percutaneous liver biopsy. - This location provides safe access to the **right lobe of the liver** while avoiding injury to the **pleura** and **lungs** superiorly and minimizing risk to the **kidney** and other abdominal organs inferiorly. - At this level, the liver is sufficiently large and the approach avoids the pleural reflection, which typically descends to the 8th-9th intercostal space. - Standard surgical textbooks (Sabiston, Schwartz) recommend the **8th-10th intercostal space**, with the 9th being most frequently used. *Incorrect Option: 5th* - The **5th intercostal space** is far too high for liver biopsy and would result in puncturing the **lung** or **pleura**, causing **pneumothorax** or hemothorax. - This space is well above the liver margin and is not suitable for hepatic access. *Incorrect Option: 7th* - While the **7th intercostal space** may occasionally be mentioned, it is generally considered **too high** for routine percutaneous liver biopsy. - This level carries increased risk of **pleural injury** as the pleural reflection may extend to this level, especially during deep inspiration. - It is not the standard or preferred approach in current surgical practice. *Incorrect Option: 11th* - The **11th intercostal space** is too low and significantly increases the risk of injuring the **right kidney** or entering the peritoneal cavity with potential injury to bowel or other abdominal structures. - This space is below the optimal liver access zone and is not recommended for routine liver biopsy.

Q: All of the following are risk factors for carcinoma of the gallbladder, EXCEPT -

Oral contraceptives. ***Oral contraceptives*** - While **oral contraceptives** can increase the risk of **gallstones**, they are not directly recognized as a specific risk factor for **gallbladder carcinoma**. - The impact of oral contraceptives on gallbladder cancer risk is generally considered to be minor or non-existent compared to established risk factors. *Typhoid carriers* - **Chronic asymptomatic carriers of Salmonella Typhi** have a significantly increased risk of developing **gallbladder carcinoma**, likely due to chronic inflammation and cellular damage. - The bacteria can reside in the gallbladder for years, leading to a persistent inflammatory state and genetic mutations. *Adenomatous gall bladder polyps* - **Adenomatous polyps** in the gallbladder are considered **premalignant lesions**, especially if they are larger than 10 mm, and are associated with an increased risk of progression to adenocarcinoma. - Their presence indicates a need for careful monitoring and often surgical removal due to their malignant potential. *Choledochal cysts* - **Choledochal cysts**, congenital dilations of the bile ducts, are well-established risk factors for **cholangiocarcinoma** (bile duct cancer) and, less commonly, **gallbladder carcinoma**. - The stasis and reflux of bile within these cysts lead to chronic irritation and inflammation, increasing the risk of malignant transformation.

Q: Which of the following is not an indication for percutaneous aspiration, injection, and reaspiration treatment in hydatid cyst?

Size 5 cm) that are symptomatic or at risk of complications. - Smaller cysts (< 5 cm) may be managed with **medical therapy alone** (albendazole) or monitored, as the risks of PAIR might outweigh the benefits in small cysts. - This is **NOT an indication** for PAIR. *Unilocular cyst* - **Unilocular cysts** (WHO CE1 and CE3a types) are ideal candidates for PAIR because their simple structure allows for effective aspiration and scolicidal agent instillation. - **Multiseptated or multiloculated cysts** are contraindications for PAIR due to multiple compartments limiting scolicidal agent distribution. - This **IS an indication** for PAIR. *Cyst in lung* - **Pulmonary hydatid cysts are a contraindication to PAIR** due to high risk of complications including anaphylaxis, bronchial spillage, pneumothorax, and empyema. - Lung cysts are primarily treated with **surgery** (cystotomy, capitonnage, or lobectomy). - However, in the context of this question, some sources may consider PAIR for lung cysts in highly selected cases, making "size < 5 cm" the more definitive non-indication. *Cyst in liver* - The **liver** is the most common site for hydatid cysts (50-70% of cases), and PAIR is a well-established and effective treatment option for hepatic hydatidosis. - PAIR is considered a safe, minimally invasive alternative to surgery for appropriately selected liver cysts. - This **IS an indication** for PAIR.

Question 1

All of the following may lead to gall bladder carcinoma except which of the following?

Accepted Answer

Echinococcus Granulosus Infection

Answer

Gall Bladder Polyps

Answer

Typhoid carriers

Answer

Exposure to carcinogens like nitrosamine

Question 2

A 60-year-old male presented with jaundice, pale stools, dark urine, and a mass in the epigastric region. Which of the following diagnoses is least likely to be the cause of these symptoms?

Accepted Answer

Chronic Cholecystitis

Answer

Biliary Cancer

Answer

Periampullary Cancer

Answer

Pancreatic Cancer

Question 3

Which of the following statements about Gallbladder carcinoma is true?

Accepted Answer

Gallstones may be a predisposing factor

Answer

Carries a good prognosis

Answer

Commonly squamous cell carcinoma

Answer

Jaundice is rare

Question 4

In which of the following conditions is ERCP not indicated?

Accepted Answer

Proximal cholangiocarcinoma

Answer

Distal CBD tumor

Answer

Hepatic porta tumor

Answer

Gall stone pancreatitis

Question 5

All of the following are causes of hemobilia, EXCEPT:

Accepted Answer

Hepatitis

Answer

Trauma to Abdomen

Answer

Rupture of hepatic artery aneurysm

Answer

Malignancy

Question 6

In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?

Accepted Answer

Type II

Answer

Type IIIb

Answer

Type I

Answer

Type IV

Answer

Type IIIa

Answer

Type III

Question 7

In a patient with acute cholecystitis, referred pain to the shoulder is known as

Accepted Answer

Boas' sign

Answer

Murphy's sign

Answer

Gray Turner sign

Answer

Cullen's sign

Question 8

What is the standard intercostal space used for hepatic biopsy?

Accepted Answer

9th

Answer

5th

Answer

7th

Answer

11th

Question 9

All of the following are risk factors for carcinoma of the gallbladder, EXCEPT -

Accepted Answer

Oral contraceptives

Answer

Adenomatous gall bladder polyps

Answer

Choledochal cysts

Answer

Typhoid carriers

Question 10

Which of the following is not an indication for percutaneous aspiration, injection, and reaspiration treatment in hydatid cyst?

Accepted Answer

Size < 5 cm

Answer

Unilocular cyst

Answer

Cyst in lung

Answer

Cyst in liver

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?